6Davies SJ ,Brown B,Bryan J, et al. Clinical evaluation of the peritoneal equilibration test: a population - based study.Nephrol Dial Transplant, 1993,8 ( 1 ) : 64 - 70.
7Shigamatau T. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int, 1997,52 ( Suppl 62) : 105 - 107.
8Coffin E, Combet S, Jamar F, et al. Expression of aquaporin-1 in a long- term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis, 1999,33(2) :383 - 388.
9Dipaolo N, Garosi G, Traversari L, et al. Mesothelial biocompatibility of peritoneal dialysis solutions. Perit Dial Int,1993,13:109.
10Topley N, Alobaidi HM, Davies M, et al. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int, 1988,34(3) :404.
5Tsilibary EC,Wissig SL. Lymphatic absorption from the piritoneal cavity: Regulation of patency of meso thelial stomata. Microvas Res, 1993,10(1) : 22.
6Christian Verger,Alan Luger,Harold L et al.Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury. Kidney Inter, 1983, 23(1): 823.
